A double-blind, placebo-controlled, randomized phase II pilot study to investigate the potential efficacy of the traditional Chinese medicine neuroaid (MLC 601) in enhancing recovery after stroke (TIERS)

Cerebrovascular Diseases

Volumn 28, Issue 5, 2009, Pages 514-521

  Kong, Keng He ^a   Wee, Seng Kwee ^a   Ng, Chwee Yin ^a   Chua, Karen ^a   Chan, Kay Fei ^a   Venketasubramanian, N ^b   Chen, Christopher ^b  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Clinical trial; Functional recovery; Motor rehabilitation; Neuroaid; Stroke

Indexed keywords

CHINESE DRUG; MLC 601; NEUROAID; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYESTHESIA; FALLING; FEMALE; FINGER CONTUSION; FOOT EDEMA; HAND DISEASE; HEADACHE; HUMAN; HYPOKALEMIA; JAUNDICE; MALE; MOTOR CORTEX; OUTCOME ASSESSMENT; PAIN; PATIENT COMPLIANCE; PERIANAL ABSCESS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEIZURE; SENSORY DYSFUNCTION; SIDE EFFECT; SINGLE BLIND PROCEDURE; THORAX PAIN; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PILOT PROJECTS; PLANT PREPARATIONS; RECOVERY OF FUNCTION; RISK FACTORS; SAMPLE SIZE; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349799488     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000247001     Document Type: Article

References (19)

1. Sze KH, Wong E, Or KH, Lum CM, Woo J: Factors predicting stroke disability at discharge: a study of 793 Chinese. Arch Phys Med Rehabil 2000; 81: 876-880.
2. Scheidtmann K, Fries W, Muller F, Koenig E: Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, doubleblind study. Lancet 2001; 358: 787-790.
3. Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN: Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94-97.
4. Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R: Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995; 26: 2254-2259.
5. Martisson L, Hardemark H, Eksborg S: Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2007; 1: CD002090.
6. Restemeyer C, Weiller C, Liepert J: No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci 2007; 25: 143-150.
7. Chen C, Venketasubramanian N, Gan R, Lambert C, Picard D, Chan B, Chan E, Bousser MG, Xuemin S: Danqi Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery. Stroke 2009; 40: 859-863.
8. Gan R, Lambert C, Lianting J, Chan E, Venketasubramanian N, Chen C, Chan B, Samama M, Bousser MG: Danqi Piantan Jiaonang does not modify hemostasis, hematology and biochemistry in normal subjects and stroke patients. Cerebrovasc Dis 2008; 25: 450-456.
9. Siow HC: NeuroAiD in stroke recovery. Eur Neurol 2008; 60: 264-266.
10. Venketasubramanian N, Chen C, Gan R, Chan B, Chang HM, Tan SB, Picard D, Navarro JC, Baroque AC, Poungvarin N, Donnan GA, Bousser MG: A double-blind, placebo- controlled, randomized, multicenter study to investigate Chinese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES Study). Int J Stroke 2009; 4: 54-60.
11. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
12. Gladstone Danells CJ, Black SE, The Fugl- Meyer Assessment of Motor Recovery after Stroke: A critical review of its measurement properties. Neurorehabil Neural Repair 2002; 16: 232-240.
13. Keith RA, Granger CV, Hamilton BB, Sherwin FS: The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1987; 1: 6-18.
14. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Herztberg V, Rorick M, Moonaw CJ, Walker M: Measurement of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
15. Duncan PW, Goldstein LB, Matchar D, Divine GW, Feussner J: Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke 1992; 23: 1084-1089.
16. Cohen J: Statistical Power Analysis for the Behavior Sciences, ed 2. Hillsdale, Erlbaum, 1988.
17. Lin KC, Wu CY, Liu JS, Chen YT, Hsu CJ: Constraint-induced therapy versus dosematched control intervention to improve motor ability, basic/extended daily functions, and quality of life in stroke. Neurorehabil Neural Repair 2009; 23: 160-165.
18. Wu CY, Chen CL, Tang SF, Lin KC, Huang YY: Kinematic and clinical analyses of upper- extremity movements after constraintinduced movement therapy in patients with stroke: a randomized controlled trial. Arch Phys Med Rehabil 2007; 88: 964-970.
19. Venketasubramanian N, Chen C: Burden of stroke in Singapore. Int J Stroke 2008; 3: 51-54.